AmbioPharm expands Aiken County operations

COLUMBIA, S.C. - AmbioPharm, Inc. (AmbioPharm), a peptide manufacturer and developer, today announced it is expanding its operations in Aiken County. The company's $118.96 million investment will create 202 new jobs.

Founded in 2005, AmbioPharm is headquartered in North Augusta and specializes in developing highly efficient peptide manufacturing processes for peptide-based active pharmaceutical ingredients (APIs) at small to very large scales. The company manufactures new chemical entities (NCEs) and peptide APIs under current good manufacturing practice (GMP) regulations for clients worldwide.

As part of its expansion, AmbioPharm will construct a modular manufacturing building at its existing South Carolina campus, located at 1024 Dittman Court in North Augusta. The facility will offer commercial-scale GMP synthesis, solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS) and hybrid approaches, all supported by semi-automated production systems and advanced solvent delivery infrastructure.

Operations are expected to be online by the end of 2027. Individuals interested in joining the AmbioPharm team should visit the company's careers page.

QUOTES

"As the global demand for peptide therapeutics accelerates, the need for dependable U.S. manufacturing is extremely important. This expansion enhances our ability to support our client-partners with scalable, high-quality production while creating new opportunities for skilled talent in Aiken County." -AmbioPharm CEO Brian Gregg

"AmbioPharm's expansion in Aiken County is a testament to the advantages of doing business in South Carolina and the opportunities available here. By adding 202 new jobs, the company is strengthening our local economy and deepening our state's position as a global leader in manufacturing." -Gov. Henry McMaster

"With an investment of $118.96 million, AmbioPharm's additional manufacturing capabilities will provide new economic opportunities in Aiken County. We are excited to witness the life sciences company's continuing growth and development in South Carolina." -Secretary of Commerce Harry M. Lightsey III

"I am pleased that AmbioPharm has chosen to make this significant investment in Aiken County. The company's expansion, totaling nearly $119 million and creating 202 new jobs, is a tremendous vote of confidence in our community, our workforce and our business climate. AmbioPharm has been a valued member of our corporate community, and the Aiken County Council is proud of their growth and success. This announcement further strengthens Aiken County's position as a leader in advanced manufacturing and life sciences." -Aiken County Council Chairman Gary Bunker

"We are proud to celebrate AmbioPharm's continued growth and commitment to North Augusta and Aiken County. This $118.96 million expansion and the creation of 202 new jobs represent a significant investment in our community and our workforce. AmbioPharm's success demonstrates the strength of our region as a destination for advanced manufacturing and life sciences, and we look forward to supporting the company's continued growth for years to come." -Western SC Economic Development Partnership Chairman Richard Pendarvis

FIVE FAST FACTS

• AmbioPharm is expanding its operations in Aiken County.
• The company's $118.96 million investment will create 202 new jobs.
• AmbioPharm is a peptide manufacturer and developer.
• The company is located at 1024 Dittman Court in North Augusta, S.C.
• Individuals interested in joining the AmbioPharm team should visit the company's careers page.